缩写名/全名 |
CLIN LUNG CANCER
Clinical Lung Cancer |
||||||||||||||||||||||||
ISSN号 | 1525-7304 | ||||||||||||||||||||||||
研究方向 | 医学-肿瘤学 | ||||||||||||||||||||||||
影响因子 | 2015:3.03, 2016:3.434, 2017:4.204, 2018:4.117, 2019:3.55, | ||||||||||||||||||||||||
出版国家 | UNITED STATES | ||||||||||||||||||||||||
出版周期 | Bimonthly | ||||||||||||||||||||||||
年文章数 | 144 | ||||||||||||||||||||||||
出版年份 | 1999 | ||||||||||||||||||||||||
是否OA | No | ||||||||||||||||||||||||
审稿周期(仅供参考) | 较慢,6-12周 |
||||||||||||||||||||||||
录用比例 | 较易 | ||||||||||||||||||||||||
投稿链接 | http://ees.elsevier.com/clc/ | ||||||||||||||||||||||||
投稿官网 | http://www.clinical-lung-cancer.com/ | ||||||||||||||||||||||||
h-index | 52 | ||||||||||||||||||||||||
CiteScore |
|
||||||||||||||||||||||||
PubMed Central (PMC)链接 | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1525-7304%5BISSN%5D | ||||||||||||||||||||||||
中科院SCI期刊分区 ( 2018年新版本) |
|
||||||||||||||||||||||||
中科院SCI期刊分区 ( 2020年新版本) |
|
中国学者近期发表的论文 | |
1. | A Patient With Lung Adenocarcinoma With BRAF Gene Fusion and Response to Vemurafenib Author: You-cai Zhu, Wen-xian Wang, Chun-wei Xu, Wu Zhuang, Kai-qi Du, Gang Chen, Tang-feng Lv, Yong Song Journal: Clinical Lung Cancer, 2019, Vol., , DOI:10.1016/j.cllc.2019.02.020 DOI |
2. | Case Report: Temporal Heterogeneity of ALK Activating Mutations in Sequential ALK TKI–Treated Non–Small-Cell Lung Cancer Revealed Using NGS-Based Liquid Biopsy Author: Meijuan Ding, Lili Deng, Ruoying Yu, Dan Lu, Yun Bai, Xue Wu, Yang W. Shao, Yu Yang Journal: Clinical Lung Cancer, 2019, Vol., , DOI:10.1016/j.cllc.2019.02.014 DOI |
3. | Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non–small-cell Lung Cancer Author: Buhai Wang, Ye Gao, Yuxiang Huang, Qiuxiang Ou, Tingting Fang, Chunhui Tang, Xue Wu, Yang W. Shao Journal: Clinical Lung Cancer, 2019, Vol., , DOI:10.1016/j.cllc.2018.12.017 DOI |
4. | Clinical Features and Prognosis of Pulmonary Lymphoepithelioma-like Carcinoma: Summary of Eighty-five Cases Author: Yinyin Qin, Guoying Gao, Xiaohong Xie, Zheng Zhu, Weijie Guan, Xinqing Lin, Zhanhong Xie, Ouyang Ming, Rongchang Chen, Nanshan Zhong, Shiyue Li, Chengzhi Zhou Journal: Clinical Lung Cancer, 2018, Vol., , DOI:10.1016/j.cllc.2018.12.014 DOI |
5. | Role of Skip Mediastinal Lymph Node Metastasis for Patients With Resectable Non–small-cell Lung Cancer: A Propensity Score Matching Analysis Author: Lin Wang, Cheng Zhan, Jie Gu, Junjie Xi, Zongwu Lin, Liang Xue, Di Ge, Qun Wang Journal: Clinical Lung Cancer, 2018, Vol., , DOI:10.1016/j.cllc.2018.12.007 DOI |
6. | Combined Use of Crizotinib and Gefitinib in Advanced Lung Adenocarcinoma With Leptomeningeal Metastases Harboring MET Amplification After the Development of Gefitinib Resistance: A Case Report and Literature Review Author: Yalun Li, Rui Zhang, Yongzhao Zhou, Juan Song, Wenxin Luo, Panwen Tian, Weimin Li Journal: Clinical Lung Cancer, 2018, Vol., , DOI:10.1016/j.cllc.2018.12.004 DOI |
7. | Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR-Mutated Advanced Non–Small-Cell Lung Cancer Patients Treated With First-Line EGFR Tyrosine Kinase Inhibitors Author: Tao Jiang, Jing Zhao, Chao Zhao, Xuefei Li, Jiqiao Shen, Juan Zhou, Shengxiang Ren, Chunxia Su, Caicun Zhou, Mary O'Brien Journal: Clinical Lung Cancer, 2018, Vol., , DOI:10.1016/j.cllc.2018.11.014 DOI |
8. | De Novo MET Amplification in Chinese Patients With Non–Small-Cell Lung Cancer and Treatment Efficacy With Crizotinib: A Multicenter Retrospective Study Author: Zhengbo Song, Hong Wang, Zongyang Yu, Peihua Lu, Chunwei Xu, Gang Chen, Yiping Zhang Journal: Clinical Lung Cancer, 2018, Vol., , DOI:10.1016/j.cllc.2018.11.007 DOI |
9. | The Association Between Imaging Features of TSCT and the Expression of PD-L1 in Patients With Surgical Resection of Lung Adenocarcinoma Author: Tong Wu, Fei Zhou, Adiilah K. Soodeen-Lalloo, Xing Yang, Yingran Shen, Xi Ding, Jinpeng Shi, Jie Dai, Jingyun Shi Journal: Clinical Lung Cancer, 2018, Vol., , DOI:10.1016/j.cllc.2018.10.012 DOI |
10. | Spread Through Air Spaces (STAS): A New Pathologic Morphology in Lung Cancer Author: Ke Ma, Cheng Zhan, Shuai Wang, Yu Shi, Wei Jiang, Qun Wang Journal: Clinical Lung Cancer, 2018, Vol., , DOI:10.1016/j.cllc.2018.10.007 DOI |
|
|